These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32085423)

  • 1. New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological Targets.
    Brullo C; Massa M; Rapetti F; Alfei S; Bertolotto MB; Montecucco F; Signorello MG; Bruno O
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32085423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Series of Pyrazoles and Imidazo-Pyrazoles Targeting Different Cancer and Inflammation Pathways.
    Signorello MG; Rapetti F; Meta E; Sidibè A; Bruno O; Brullo C
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of New Antiproliferative Imidazopyrazole Acylhydrazones Able To Interact with Microtubule Systems.
    Brullo C; Rapetti F; Alfei S; Maric I; Rizzelli F; Mapelli M; Rosano C; Viale M; Bruno O
    ChemMedChem; 2020 Jun; 15(11):961-969. PubMed ID: 32233110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors.
    Li YS; Tian H; Zhao DS; Hu DK; Liu XY; Jin HW; Song GP; Cui ZN
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3632-5. PubMed ID: 27289320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of N-pyrazolyl-N'-alkyl/benzyl/phenylureas: a new class of potent inhibitors of interleukin 8-induced neutrophil chemotaxis.
    Bruno O; Brullo C; Bondavalli F; Schenone S; Ranise A; Arduino N; Bertolotto MB; Montecucco F; Ottonello L; Dallegri F; Tognolini M; Ballabeni V; Bertoni S; Barocelli E
    J Med Chem; 2007 Jul; 50(15):3618-26. PubMed ID: 17608466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of chalcone derivatives as inhibitors of neutrophils' chemotaxis, phagocytosis and production of reactive oxygen species.
    Bukhari SN; Tajuddin Y; Benedict VJ; Lam KW; Jantan I; Jalil J; Jasamai M
    Chem Biol Drug Des; 2014 Feb; 83(2):198-206. PubMed ID: 24433224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 4-alkynyl pyrazoles as inhibitors of PDE4: a practical access via Pd/C-Cu catalysis.
    Gorja DR; Shiva Kumar K; Kandale A; Meda CL; Parsa KV; Mukkanti K; Pal M
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2480-7. PubMed ID: 22381049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
    Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
    Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti-inflammatory/Antioxidant Agents.
    Cichero E; Rapetti F; Lusardi M; Scarano N; Alfei S; Altieri P; Garibaldi S; Ameri P; Grazia Signorello M; Brullo C
    ChemMedChem; 2023 May; 18(9):e202300046. PubMed ID: 36806572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrazole and imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis Agents.
    Meta E; Brullo C; Tonelli M; Franzblau SG; Wang Y; Ma R; Baojie W; Orena BS; Pasca MR; Bruno O
    Med Chem; 2019; 15(1):17-27. PubMed ID: 29792151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Aryl-2-phenyl-2,3-dihydro-imidazo[1,2-b]pyrazole-1-carboxamides 7-substituted strongly inhibiting both fMLP-OMe- and IL-8-induced human neutrophil chemotaxis.
    Brullo C; Spisani S; Selvatici R; Bruno O
    Eur J Med Chem; 2012 Jan; 47(1):573-9. PubMed ID: 22152986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of oxazole-based PDE4 inhibitors with picomolar potency.
    Kuang R; Shue HJ; Xiao L; Blythin DJ; Shih NY; Chen X; Gu D; Schwerdt J; Lin L; Ting PC; Cao J; Aslanian R; Piwinski JJ; Prelusky D; Wu P; Zhang J; Zhang X; Celly CS; Billah M; Wang P
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2594-7. PubMed ID: 22401864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Activity Relationship Studies on Highly Functionalized Pyrazole Hydrazones and Amides as Antiproliferative and Antioxidant Agents.
    Lusardi M; Signorello MG; Russo E; Caviglia D; Ponassi M; Iervasi E; Rosano C; Brullo C; Spallarossa A
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and effects of pyrazolines and isoxazoles on the phagocytic chemotaxis and release of reactive oxygen species by zymosan stimulated human neutrophils.
    Bukhari SN; Jantan I; Wai LK; Lajis NH; Abbas F; Jasamai M
    Med Chem; 2013 Dec; 9(8):1091-8. PubMed ID: 23092331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 2,3-disubstituted pyridines as potent, orally active PDE4 inhibitors.
    Kato Y; Kawasaki M; Nigo T; Nakamura S; Fusano A; Teranishi Y; Ito MN; Sumiyoshi T
    Bioorg Med Chem; 2013 Sep; 21(18):5851-4. PubMed ID: 23910988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7.
    Sharma H; Lather V; Grewal AS; Pandita D
    Curr Comput Aided Drug Des; 2019; 15(3):225-234. PubMed ID: 30280674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrazole derivatives as antitumor, anti-inflammatory and antibacterial agents.
    Liu JJ; Zhao MY; Zhang X; Zhao X; Zhu HL
    Mini Rev Med Chem; 2013 Nov; 13(13):1957-66. PubMed ID: 23937232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 3,5-disubstituted-1,2,4-oxadiazoles as potent inhibitors of phosphodiesterase4b2.
    Kumar D; Patel G; Vijayakrishnan L; Dastidar SG; Ray A
    Chem Biol Drug Des; 2012 May; 79(5):810-8. PubMed ID: 22176507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis.
    Bruno O; Brullo C; Bondavalli F; Ranise A; Schenone S; Falzarano MS; Varani K; Spisani S
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3696-701. PubMed ID: 17475488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrazolopyridines as potent PDE4B inhibitors: 5-heterocycle SAR.
    Mitchell CJ; Ballantine SP; Coe DM; Cook CM; Delves CJ; Dowle MD; Edlin CD; Hamblin JN; Holman S; Johnson MR; Jones PS; Keeling SE; Kranz M; Lindvall M; Lucas FS; Neu M; Solanke YE; Somers DO; Trivedi NA; Wiseman JO
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5803-6. PubMed ID: 20732811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.